Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CASI - CASI Pharmaceuticals Inc


Previous close
6.54
0   0%

Share volume: 3,853
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$6.54
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30 2022-12-31
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022 Q4 2022
Report Date 2022-05-12 2022-08-12 2022-11-14 2023-04-26
Assets
Total Assets 129.564 M 118.857 M 127.906 M 96.234 M
Current Assets 52.695 M 42.284 M 55.612 M 73.423 M
Inventories 3.721 M 5.791 M 5.773 M 6.138 M
Other Current Assets 1.404 M 1.666 M 1.728 M 2.975 M
Short Term Investments 1.404 M 7.371 M 8.037 M 5.738 M
Total Receivables 10.086 M 10.260 M 12.560 M 12.973 M
Current Cash 37.484 M 18.862 M 26.742 M 48.574 M
Total Non-current Assets 76.869 M 76.573 M 72.294 M 22.811 M
Property Plant Equipment 14.580 M 14.853 M 13.867 M 11.831 M
Other Assets 1.260 M 635.000 K 932.000 K 1.056 M
Intangible Assets 11.900 M 10.952 M 10.049 M 1.063 M
Goodwill 0.000 0.000 0.000 0.000
Liabilities and shareholders’ equity
Total Liabilities and shareholders’ equity 129.564 M 118.857 M 127.906 M 96.234 M
Total liabilities 54.575 M 51.914 M 66.195 M 51.660 M
Total current liabilities 13.872 M 13.175 M 29.749 M 17.005 M
Accounts Payable 7.171 M 4.598 M 3.098 M 3.289 M
Other liabilities 16.977 M 15.220 M 14.309 M 11.821 M
Current long term debt 0.000 1.001 M 3.000 M 0.000
Long term debt 0.000 0.000 0.000 0.000
Other liabilities 16.977 M 15.220 M 14.309 M 11.821 M
Minority interest 23.726 M 22.661 M 21.503 M 22.358 M
Total Shareholder equity 74.989 M 66.943 M 61.711 M 44.574 M
Common stock 137.956 M 13.606 M 13.606 M 13.582 M
Retained earnings -613.626 M -620.571 M -624.856 M -637.160 M